Showing results (361-370 of 385) with videos related to
Sort By:
Pageof 39
Brain : a Journal of Neurology|September 16, 2020
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosisMaria Pia Amato, Mattia Fonderico, Emilio Portaccio, et al.Neurology|December 21, 2022
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple SclerosisGiacomo Boffa, Alessio Signori, Luca Massacesi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 16, 2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS RegisterPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.Journal of Clinical Medicine|March 29, 2023
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and DepressionCristiano Scandurra, Laura Rosa, Antonio Carotenuto, et al.Ebiomedicine|September 26, 2021
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapiesMaria Pia Sormani, Matilde Inglese, Irene Schiavetti, et al.Neurology|May 30, 2014
Defining the clinical course of multiple sclerosis: the 2013 revisionsFred D Lublin, Stephen C Reingold, Jeffrey A Cohen, et al.Ebiomedicine|May 8, 2022
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in ItalyMaria Pia Sormani, Irene Schiavetti, Matilde Inglese, et al.Multiple Sclerosis and Related Disorders|October 26, 2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Irene Schiavetti, Roberto Bergamaschi, et al.Journal of Neurology|June 28, 2021
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective studyClara G Chisari, Giancarlo Comi, Massimo Filippi, et al.Cerebellum (London, England)|April 13, 2022
Consensus Paper: Ataxic GaitPierre Cabaraux, Sunil K Agrawal, Huaying Cai, et al.Pageof 39